<code id='124FB50A84'></code><style id='124FB50A84'></style>
    • <acronym id='124FB50A84'></acronym>
      <center id='124FB50A84'><center id='124FB50A84'><tfoot id='124FB50A84'></tfoot></center><abbr id='124FB50A84'><dir id='124FB50A84'><tfoot id='124FB50A84'></tfoot><noframes id='124FB50A84'>

    • <optgroup id='124FB50A84'><strike id='124FB50A84'><sup id='124FB50A84'></sup></strike><code id='124FB50A84'></code></optgroup>
        1. <b id='124FB50A84'><label id='124FB50A84'><select id='124FB50A84'><dt id='124FB50A84'><span id='124FB50A84'></span></dt></select></label></b><u id='124FB50A84'></u>
          <i id='124FB50A84'><strike id='124FB50A84'><tt id='124FB50A84'><pre id='124FB50A84'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:275
          Three boxes of Wegovy stands in a line — coverage from STAT
          Steffen Trumpf/picture alliance/Getty Images

          WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

          Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

          advertisement

          Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          Why doctors need education on FDA device approval process
          Why doctors need education on FDA device approval process

          AdobeInherfinalpresentationforhealthpolicyclassattheUniversityofChicago,first-yearmedicalstudentRobi

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          Readout Newsletter: Merck, J&J, and long Covid

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo